Abstract
Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) expression is often silenced in many types of human tumors. However, the relationship between RIZ1 expression and malignant meningiomas remains unclear. Here we have found for the first time that the expression of RIZ1 genes are associated with meningiomas progression through extensive analyses of Affymetrix GeneChip microarray data. Further validation methods for gene expression included quantitative PCR (qPCR), western blot and immunohistochemistry analysis, and these methods confirmed that RIZ1 is significantly downregulated in malignant meningioma tissues, as compared with benign meningiomas. In addition, malignant meningioma cells were stably transfected with ectogenic RIZ1 using Lentivirus-mediated transfection, and the transfections were followed by an in vitro 5-bromo-2-deoxyuridin incorporation assay, colony formation assay, cell cycle analysis, invasive analysis, apoptotic assay and western blot analysis. Our results demonstrate that the forced expression of RIZ1 in a malignant meningioma cell line inhibited cellular proliferation and arrested the cells in the G2/M phase of the cell cycle. We also confirmed that overexpression of RIZ1 may induce apoptosis of malignant meningioma cells. Furthermore, RIZ1 overexpression in malignant meningioma cells was associated with the downregulation of c-myc expression. These results from our study indicate that RIZ1 expression is significantly downregulated as the formation of meningiomas progressed, and suggest that RIZ1 may represent a promising candidate tumor suppressor gene that contributes to malignant meningiomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97–109.
Glaholm J, Bloom HJ, Crow JH . The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 1990; 18: 755–761.
Goldsmith BJ, Wara WM, Wilson CB, Larson DA . Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994; 80: 195–201.
Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC . ‘Malignancy’ in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85: 2046–2056.
Ware ML, Larson DA, Sneed PK, Wara WW, McDermott MW . Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma. Neurosurgery 2004; 54: 55–63.
Carling T, Kim KC, Yang XH, Gu J, Zhang XK, Huang S . A histone methyltransferase is required for maximal response to female sex hormones. Mol Cell Biol 2004; 24: 7032–7042.
Buyse IM, Shao G, Huang S . The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci USA 1995; 92: 4467–4471.
Huang S, Shao G, Liu L . The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem 1998; 273: 15933–15939.
Liu L, Shao G, Steele-Perkins G, Huang S . The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem 1997; 272: 2984–2991.
Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406: 593–599.
Chadwick RB, Jiang GL, Bennington GA, Yuan B, Johnson CK, Stevens MW et al. Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci USA 2000; 97: 2662–2667.
He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC et al. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 1998; 58: 4238–4244.
Jiang G, Liu L, Buyse IM, Simon D, Huang S . Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 1999; 83: 541–546.
Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 2001; 15: 2250–2262.
Piao Z, Fang W, Malkhosyan S, Kim H, Horii A, Perucho M et al. Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Cancer Res 2000; 60: 4701–4704.
Jiang GL, Huang S . Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers. Cancer Res 2001; 61: 1796–1798.
Tao Y, Wei Q, Xu Z, Bai R, Li Y, Luo C et al. Holistic and network analysis of meningioma pathogenesis and malignancy. Biofactors 2006; 28: 203–219.
Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M et al. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2. J Cell Physiol 2009; 221: 771–777.
Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 2010; 70: 2350–2358.
Modha A, Gutin PH . Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 2005; 57: 538–550.
Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 1997; 94: 14719–14724.
Shadat NM, Koide N, Khuda, Dagvadorj J, Tumurkhuu G, Naiki Y et al. Retinoblastoma protein interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53. Cancer Invest 2001; 28: 806–812.
Gazzerro P, Abbondanza C, D'Arcangelo A, Rossi M, Medici N, Moncharmont B et al. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Exp Cell Res 2006; 312: 340–349.
Lee WH . Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 1990; 27: 389–395.
Kim Y, Shintani S, Kohno Y, Zhang R, Wong DT . Cyclin G2 dysregulation in human oral cancer. Cancer Res 2004; 64: 8980–8986.
Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B et al. Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 2002; 87: 1262–1267.
Wang J, Wang Q, Cui Y, Liu ZY, Zhao W, Wang CL et al. Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. J Neurooncol 2012; 106: 473–484.
Acknowledgements
The meningioma cell line IOMM-Lee and CH157-MN were kindly provided by Professor Randy Jensen and Dr David Gillespie (Utah State University, USA). The research was supported by Shanghai Science and Technology Foundation of China: 08431900400 (Guohan Hu), Shanghai Science and Technology Foundation of China: 09411950900 (Jianchun Liao), Shanghai Science and Technology Youth Fund of China: 09ZR410000 (Huanhai Liu) and Natural Sciences Fund Project of Anhui Province, China: No. 11040606M212 (Chunlin Wang).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Liu, Z., Wang, J., Liu, H. et al. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Oncogene 32, 1216–1222 (2013). https://doi.org/10.1038/onc.2012.155
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2012.155
Keywords
This article is cited by
-
Tumor-suppressive functions of protein lysine methyltransferases
Experimental & Molecular Medicine (2023)
-
Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway
BMC Cancer (2018)
-
Repression of Akt3 gene transcription by the tumor suppressor RIZ1
Scientific Reports (2018)
-
Synergism between RIZ1 gene therapy and paclitaxel in SiHa cervical cancer cells
Cancer Gene Therapy (2016)
-
Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
BMC Cancer (2015)